“…104 Cross-reactivity among heparins is frequently reported, both for non-immediate ADR and immediate ADR. The distribution of cross-reactions is independent of the heparin molecular weight 106,107 , while fondaparinux, which is a fully synthetic pentasaccharide inactivating activated factor X, is considered a safe and effective alternative, 101,102 even though cases of cross-reactivity between fondaparinux and other heparins have been described, with different incidence rate (from 0.4% 101 to 10.4%, 107 up to 25% in small case series 108 ). In case of non-immediate ADR to subcutaneously injected heparin, intravenous administration of the drug should be tolerated, may be because of differential processing on presentation of antigens depending on the route of administration.…”